At the same time, therapy targeting the NF-κB pathway can also inhibit the proliferation, migration and invasion of tumor cells and induce apoptosis, which is complementary to the mechanism of action of chemotherapy drugs and plays a synergistic role (64). This evidence concerns the gene NFKB1 and neoplasm.